Artwork

Content provided by Sam Tarantino. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sam Tarantino or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

COVID-19 Special Edition – Canadian Access to Future Coronovirus Treatment – Canadian Regulatory Framework

31:10
 
Share
 

Manage episode 337505501 series 3381582
Content provided by Sam Tarantino. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sam Tarantino or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode I spoke with Nathaniel Lipkus, intellectual property litigator, and partner at Osler, Hoskin & Harcourt LLP.

Nate is a legal expert on patent and regulatory issues facing pharmaceutical and biotechnology companies.

Nate has also published extensively on topics pertaining to Canada’s Patent Act . Nate recently wrote an article for the Globe and Mail exploring today’s topic.
In this episode, Nate provides insight on Canada's regulatory framework and how it can assist Canadian access to new therapeutics to the novel coronavirus. Specifically, we explore the COVID-19 Emergency Response Act (Bill C-13) and its provisions.
We also explore Canada’s industrial capability to meet future demand to treatment.
CONTACT INFORMATION

nlipkus@osler.com

  continue reading

26 episodes

Artwork
iconShare
 
Manage episode 337505501 series 3381582
Content provided by Sam Tarantino. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sam Tarantino or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode I spoke with Nathaniel Lipkus, intellectual property litigator, and partner at Osler, Hoskin & Harcourt LLP.

Nate is a legal expert on patent and regulatory issues facing pharmaceutical and biotechnology companies.

Nate has also published extensively on topics pertaining to Canada’s Patent Act . Nate recently wrote an article for the Globe and Mail exploring today’s topic.
In this episode, Nate provides insight on Canada's regulatory framework and how it can assist Canadian access to new therapeutics to the novel coronavirus. Specifically, we explore the COVID-19 Emergency Response Act (Bill C-13) and its provisions.
We also explore Canada’s industrial capability to meet future demand to treatment.
CONTACT INFORMATION

nlipkus@osler.com

  continue reading

26 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide